Dr. Duffield on Implications for Immunotherapy in Nasopharyngeal Carcinoma – OncLive
OncLive |
Dr. Duffield on Implications for Immunotherapy in Nasopharyngeal Carcinoma
OncLive Amy Duffield, MD, PhD, assistant professor of pathology, Johns Hopkins University School of Medicine, member, Johns Hopkins Kimmel Cancer Center, discusses the implications for immunotherapy in nasopharyngeal carcinoma. Nasopharyngeal carcinoma is … |
